Is OPK Worth Buying in 2026?

Opko Health Inc.

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-07-26

Here’s whether Opko Health Inc. (OPK) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bearish.

🔴
Bearish

Positives: 50-day MA is rising (+1.25% over 10 days). Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); RSI 17 — oversold; weak 1-year return of -12.9%. Currently 24.0% off its 52-week high. Score: -4/7.

Ready to act on this? 📈 Trade on Webull

OPK is trading below its 200-day MA ($1.30) — a key warning sign the longer-term trend is under pressure. An RSI of 16.7 has dropped into oversold territory, which has historically preceded short-term bounces. The 1-year return of -12.9% compares to +16.5% for SPY (trailed the market by 29.3%). The current 24.0% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $8,714 today
vs. S&P 500 (SPY) — same period trailed market by 29.3%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($1.30)
Above 50-day MA ($1.35)
!RSI(14) neutral zone (30–70) — currently 16.7
Positive return (-12.9%)
!Within 10% of period high (−24.0%)
Period Range $1.22
$0.98 $1.61
RSI (14) 16.7
0 · OversoldOverbought · 100

Key Metrics

Price$1.22
Period Return-12.9%
Period High$1.61
Period Low$0.98
Drawdown−24.0%
MA-50$1.35
MA-200$1.30
RSI (14)16.7
Avg Volume (30d)3.0M
vs. SPYtrailed by 29.3%
Return Rank#640 of 999

Trade OPK

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers